12:00 AM
 | 
Dec 24, 2001
 |  BioCentury  |  Finance

Analyst picks & changes

Amgen Inc. (AMGN), Thousand Oaks, Calif.

Business: Biopharmaceuticals

Deutsche Banc Alex. Brown analyst Dennis Harp lowered his rating to "buy" from "strong buy" and reduced his price target...

Read the full 128 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >